It was the worst thing I have ever done to my skin. There was no way I could get over to my dad’s that evening with this stuff on my face. The lower third of my face was blue! I was trying out a new product for removing some excess…
Discussion
A 58-year-old woman who developed cold agglutinin disease (CAD) as a complication of blood cancer improved after treatment with medications to reduce the immune attack on red blood cells, along with chemotherapy for the underlying cancer. Meanwhile, corticosteroids and other medications helped two patients with different forms of autoimmune…
Discussion
Da-dahda-da! Off goes the blasted alarm on my husband’s phone at 7:45 a.m. How I hate it. I didn’t get more than a wink of sleep. I tossed and turned, first under the covers because I was too cold, then with one leg and then the other poking out because…
Discussion
Gilead Sciences and Lakefront Biotherapeutics have acquired Ouro Medicines and its investigational therapy, gamgertamig, for cold agglutinin disease (CAD) and other forms of autoimmune hemolytic anemia (AIHA). Gamgertamig is also being developed as a treatment for several other autoimmune diseases. Under the deal, valued at up to $2.175 billion,…
Discussion
I looked around the yard in dismay after walking through the rotting wooden door of our screened-in back porch to assess the challenges before me. The backyard of our Alabama home didn’t look like this when my husband, Mike, and I left it last summer for our work in Indonesia.
Cold agglutinin disease (CAD) is a rare disorder in which the immune system mistakenly attacks red blood cells, resulting in anemia.
CAD is characterized by autoantibodies, called cold agglutinins, binding to and activating the destruction of red blood cells when exposed to cold temperatures.
Symptoms of CAD include fatigue, Raynaud’s syndrome, joint pain, jaundice or skin discoloration, and heart problems. These symptoms can worsen with more cold exposure.
Get regular updates to your inbox.
